This is a monocentric, comparative, open-label, randomized, crossover study enrolling patients hospitalized in Strasbourg Europe Cancerology Institute, receiving repeated invasive care for cancer treatment.

The purpose of this study is to compare the satisfaction of patients, regarding their perception of care, with or without Snoezelen session.

Patients will followed during two visits for a repeated invasive care. They will be randomized to two groups in a 1:1 ratio.

Crossover plan and arms are described as follow:

Arm A : Visit 1 with Snoezelen session before invasive care and Visit 2 without Snoezelen session before invasive care (standard care)

Arm B : Visit 1 without Snoezelen session before invasive care (standard care) and Visit 2 with Snoezelen session before invasive care

Inclusion Criteria:

• Patients treated for cancer and hospitalized for invasive care
• Two programmed hospitalization for repeated care
• Patients receiving one of the following invasive care: Huber needle application (transfusion, parenteral nutrition), complex wound dressing, intrathecal chemotherapy, ascites fluid or pleural puncture
• Patients must be ≥ 18 years old
• Performance Status ≤ 3
• Absence of psychiatric disorder impairing follow-up
• Ability to speak, understand, write and read French
• Signed informed consent from the patient
• Affiliation to social security system

Exclusion Criteria:

• Patients presenting infectious symptoms requiring isolation
• Patients < 18 years old or patients ≥ 18 years old under supervision
• Patients placed under judicial protection or guardianship
• Women that are pregnant or breast-feeding